The enlarged prostate presses on and blocks the urethra, causing bothersome urinary symptoms like urgent need to urinate, difficulty starting your urine stream, need to push or strain when urinating, dribbling, incomplete emptying, weak urine flow, increased frequency of urination, burning or pain during urination, and frequent nighttime urination.1,2 Luckily, there are treatment options that can help.
Most men living with enlarged prostate (BPH) symptoms take prescription medications after they’re diagnosed, although these often don’t provide adequate relief and may cause dizziness, fatigue, and sexual dysfunction.3 Medications may not need to be a lifelong burden, however, and men don’t need to wait until surgery is required to address the problem. In fact, they may be able to avoid traditional surgery altogether.
There is no pharmacological cure for BPH but your doctor may prescribe medications to manage your symptoms. These medications include alpha blockers which relax the muscles around the neck of your bladder, making it easier to urinate, and alpha reductase inhibitors which act to shrink the prostate. While medications can be helpful in relieving symptoms for some men, medications must be continued to maintain the effects.
An issue with prescriptions is their effectiveness may be inadequate and they may cause dizziness, fatigue, and sexual dysfunction.3 These, along with other side effects, are an unnecessary burden and can make men feel older than their age.
The UroLift System is a proven option for patients looking for an alternative to drugs or major surgery. The UroLift System treatment is often performed in an ambulatory setting using implants to hold open the obstructed pathway that’s blocking urine flow, addressing the blockage, not just continuously treating enlarged prostate (BPH) symptoms.
The UroLift treatment does not require cutting, heating, removal, or destruction of the tissue.3-8 Most patients typically do not require ongoing BPH medications.9 The UroLift System offers a proven treatment with minimal risk of adverse events while preserving sexual function9*. The goal of the UroLift System treatment is to relieve symptoms so you can get back to your life and resume your daily activities. The UroLift System has the lowest catheter rate of the leading BPH procedures.6,9-13 The majority of patients return home on the same day without a catheter following their treatment. 4,5
Most common side effects are temporary and can include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and/or the inability to control the urge.5
Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention.
Treatment using the UROLIFT System is not appropriate if you have a prostate volume greater than 100cc, a urinary tract infection or other conditions that can be identified by your urologist.
Learn more about how the UroLift System treatment works or visit our FAQ page for more information on the benefits, risks, and recovery.
*No new onset, sustained erectile or ejaculatory dysfunction.
Ejaculatory dysfunction in the LIFT pivotal study
Thermotherapies are moderately invasive treatments applying heat energy such as microwave, radiofrequency or steam/water vapor directly to prostate tissue. Less invasive than Transurethral Resection of the Prostate (TURP) (see below), these treatments are generally safe, can be performed under local anesthesia. Applying high heat to the prostate can cause tissue swelling and urinary symptoms during the healing period. There is also an incidence of erectile and ejaculatory dysfunction with thermotherapy procedures.3 Patients often need to have a catheter inserted into their bladder during the recovery period.
Prostate laser surgery uses concentrated high powered laser light to generate precise and intense heat to remove excess tissue that may be preventing urine flow. Laser therapy lessens the bleeding risks of traditional TURP. However, since prostate tissue is still removed, there can be tissue swelling. Typically, a catheter has to be inserted into the bladder after the procedure. The most prevalent laser procedures are called photoselective vaporization of the prostate (PVP) or holmium laser enucleation (HoLEP).3
During the Transurethral Resection of the Prostate (TURP) procedure, patients undergo general anesthesia, and prostate tissue is removed by cutting. After prostate tissue has been removed, patients may have a recovery period that includes short-term problems such as bleeding, infection, erectile dysfunction, and urinary incontinence3. Patients will require a catheter that is inserted into their bladder for several days after the procedure. Symptom relief may not occur immediately, but for some patients it provides the most symptom relief of any procedure and lasts a long time. There can be long-term side effects after TURP such as dry orgasm (retrograde ejaculation), erectile dysfunction or incontinence (leaking of urine).3
1. Rosenberg, Int J Clin Pract 2007
2. Vuichoud, Can J Urol 2015
3. AUA Guidelines 2003,2020
4. Roehrborn, J Urol 2013;
5 Mirakhur, Can Assoc Rad J 2017;
6. McVary, J Urol 2016,
7. Gilling, Can J Urol 2020;
8. Kadner, World J Urol 2021
9. Roehrborn et al. Can J Urol 2017
10. Shore, Can J Urol 2014
11. Bachmann, Eur Urol 2013
12. Mollengarden, Prostate Cancer Prostatic Dis 2018
13. Gilling, J Urol 2017
INFORMATION FOR PATIENTS ABOUT THE UROLIFT® SYSTEM
The UroLift System’s implants, which can be delivered during an outpatient procedure, relieve prostate obstruction without heating, cutting, destruction of, or removing prostate tissue.
The UroLift System can be used to treat a broad spectrum of anatomies, including obstructive median lobe.1 It is the only leading BPH procedure shown to not cause new onset, sustained erectile or ejaculatory dysfunction.*2-4
Most common side effects are temporary and can include pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate and/or the inability to control the urge.5 Rare side effects, including bleeding and infection, may lead to a serious outcome and may require intervention.
Treatment using the UroLift System is not appropriate if you have a prostate volume greater than 100cc, a urinary tract infection or other conditions that can be identified by your urologist.
Individual results with the UroLift System may vary.
1) THE UROLIFT SYSTEM’S IMPLANTS ARE PERMANENT (THAT IS TO SAY: ONCE IMPLANTED, THEY CANNOT BE COMPLETELY REMOVED).
2) THE UROLIFT SYSTEM’S IMPLANTS CONTAIN STAINLESS STEEL AND NITINOL, AN ALLOY OF NICKEL AND TITANIUM. INDIVIDUALS WHO ARE ALLERGIC TO THESE METALS MAY SUFFER AN ALLERGIC REACTION TO THE IMPLANT. PRIOR TO HAVING A UROLIFT SYSTEM PROCEDURE, YOU SHOULD DISCUSS ANY ALLERGY/HYPERSENSITIVITY TO THESE MATERIALS WITH YOUR UROLOGIST.
3) THE ABOVEMENTIONED INFORMATION IS NOT INTENDED TO PROVIDE MEDICAL ADVICE TO PATIENTS OR TO REPLACE THEIR DOCTORS' EXPERT OPINION AND CARE.
4) ONLY A DOCTOR CAN DIAGNOSE WHETHER HIS/HER PATIENT HAS BPH, ASSESS HIS INDIVIDUAL CONDITION AND DEFINE WHETHER UROLIFT SYSTEM IS THE ADEQUATE TREATMENT OR NOT.
5) TALK TO YOUR UROLOGIST FOR MORE INFORMATION ABOUT THE UROLIFT SYSTEM AND TO DETERMINE IF IT IS THE RIGHT TREATMENT FOR YOU.
*No instances of new, sustained erectile or ejaculatory dysfunction in the L.I.F.T. pivotal study.
Teleflex, BPH Relief In Sight and UroLift are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. ©2023 Teleflex Incorporated. All rights reserved. Revised: 02/2023. MC-008657 LA EN
Teleflex Medical Brasil Ltda
Rua Alexandre Dumas, 2100/132 - Chacara Santo Antonio
São Paulo/SP - CEP 04717-913